Article info
Hepatology
Original article
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study
- Correspondence to Dr Christophe Hézode, CHU Henri Mondor Service Hépato-Gastroentérologie, Unité C 13ème étage, 51 avenue du Maréchal de Lattre de Tassigny, Creteil Cedex 94010, France; christophe.hezode{at}hmn.aphp.fr
Citation
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study
Publication history
- Received April 17, 2014
- Revised June 13, 2014
- Accepted July 1, 2014
- First published July 30, 2014.
Online issue publication
February 01, 2017
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions